Common Single Nucleotide Polymorphisms in Genes Related to Immune Function and Risk of Papillary Thyroid Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Brenner, Alina V ^a   Neta, Gila ^a   Sturgis, Erich M ^b   Pfeiffer, Ruth M ^a   Hutchinson, Amy ^c   Yeager, Meredith ^c   Xu, Li ^b   Zhou, Cindy ^d   Wheeler, William ^e   Tucker, Margaret A ^a   Chanock, Stephen J ^a   Sigurdson, Alice J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SAIC FREDERICK INC   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FALSE DISCOVERY RATE; FCGR2A GENE; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEMGN GENE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNITY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; SERPINA5 GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; THYROID CARCINOMA; TICAM1 GENE;

ADULT; AGED; AUTOIMMUNE DISEASES; BLOOD COAGULATION; CARCINOMA; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN C INHIBITOR; RISK FACTORS; THYROID NEOPLASMS;

EID: 84874780525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057243     Document Type: Article

References (42)

1. Sipos JA, Mazzaferri EL, (2010) Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 22: 395-404.
2. Davies L, Welch HG, (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167.
3. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, et al. (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18: 784-791.
4. Rahbari R, Zhang L, Kebebew E, (2010) Thyroid cancer gender disparity. Future Oncol 6: 1771-1779.
5. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, et al. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141: 259-277.
6. Sinnott B, Ron E, Schneider AB, (2010) Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 31: 756-773.
7. Xu L, Li G, Wei Q, El-Naggar AK, Sturgis EM, (2012) Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer 118: 1228-1235.
8. Brindel P, Doyon F, Bourgain C, Rachedi F, Boissin JL, et al. (2010) Family history of thyroid cancer and the risk of differentiated thyroid cancer in French polynesia. Thyroid 20: 393-400.
9. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41: 460-464.
10. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, et al. (2010) The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19: 2516-2523.
11. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, et al. (2009) The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5: e1000637.
12. Bozec A, Lassalle S, Hofman V, Ilie M, Santini J, et al. (2010) The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. Curr Med Chem 17: 3449-3461.
13. Guarino V, Castellone MD, Avilla E, Melillo RM, (2010) Thyroid cancer and inflammation. Mol Cell Endocrinol 321: 94-102.
14. Moss SF, Blaser MJ (2005) Mechanisms of disease: Inflammation and the origins of cancer. Nat Clin Pract Oncol 2: 90-97; quiz 91 p following 113.
15. Weng MY, Huang YT, Liu MF, Lu TH, (2012) Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan. Ann Rheum Dis 71: 524-527.
16. Prasad ML, Huang Y, Pellegata NS, de la Chapelle A, Kloos RT, (2004) Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology 45: 39-46.
17. Muzza M, Degl'Innocenti D, Colombo C, Perrino M, Ravasi E, et al. (2010) The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72: 702-708.
18. Kivity S, Ehrenfeld M, (2010) Can we explain the higher prevalence of autoimmune disease in women? Expert Rev Clin Immunol 6: 691-694.
19. Vandenbroeck K, (2012) Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies. J Interferon Cytokine Res 32: 139-151.
20. Cooper JD, Simmonds MJ, Walker NM, Burren O, Brand OJ, et al. (2012) Seven newly identified loci for autoimmune thyroid disease. Hum Mol Genet.
21. Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, et al. (2003) Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 97: 3080-3089.
22. Ho T, Li G, Lu J, Zhao C, Wei Q, et al. (2009) Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 19: 129-135.
23. Lönn S, Bhatti P, Alexander B, Pineda M, Doody M, et al. (2007) Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: A nested case-control study within a cohort of US radiologic technologists. Cancer Epidemiology Biomarkers and Prevention 16: 174-177.
24. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
25. Tarone RE, (1990) A modified Bonferroni method for discrete data. Biometrics 46: 515-522.
26. Loza MJ, McCall CE, Li L, Isaacs WB, Xu J, et al. (2007) Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS One 2: e1035.
27. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
28. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al. (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33: 700-709.
29. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
30. Meijers JC, Herwald H, (2011) Protein C inhibitor. Semin Thromb Hemost 37: 349-354.
31. Malmstrom E, Morgelin M, Malmsten M, Johansson L, Norrby-Teglund A, et al. (2009) Protein C inhibitor-a novel antimicrobial agent. PLoS Pathog 5: e1000698.
32. Suzuki K, (2008) The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis. J Thromb Haemost 6: 2017-2026.
33. Espana F, Navarro S, Medina P, Zorio E, Estelles A, (2007) The role of protein C inhibitor in human reproduction. Semin Thromb Hemost 33: 41-45.
34. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, et al. (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451: 1076-1081.
35. Bijsmans IT, Smits KM, de Graeff P, Wisman GB, van der Zee AG, et al. (2011) Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors. Mod Pathol 24: 463-470.
36. Vierlinger K, Mansfeld MH, Koperek O, Nohammer C, Kaserer K, et al. (2011) Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation. BMC Med Genomics 4: 30.
37. Stein L, Rothschild J, Luce J, Cowell JK, Thomas G, et al. (2010) Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients. Thyroid 20: 475-487.
38. Bungum M, Giwercman A, Bungum L, Humaidan P, Rastkhani H, et al. (2010) Polymorphisms in the protein C inhibitor gene in in vitro fertilization failure. Fertil Steril 93: 277-279.
39. Borgmann S, Endisch G, Urban S, Sitter T, Fricke H, (2001) A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis. Clin Immunol 98: 244-248.
40. Castanet M, Polak M, (2010) Spectrum of Human Foxe1/TTF2 Mutations. Horm Res Paediatr 73: 423-429.
41. Denny JC, Crawford DC, Ritchie MD, Bielinski SJ, Basford MA, et al. (2011) Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet 89: 529-542.
42. Eriksson N, Tung JY, Kiefer AK, Hinds DA, Francke U, et al. (2012) Novel associations for hypothyroidism include known autoimmune risk loci. PLoS One 7: e34442.